Johnson & Johnson Boosts U.S. Presence with $1 Billion+ Investment in Next‑Gen Cell Therapy Facility

Advanced manufacturing site will utilize cutting‑edge cell therapy technologies to help deliver the company’s portfolio of transformational medicines